Diligence memo · auto-generated · as of July 2, 2026
In-House Health, Inc.
In-House Health, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
In-House Health, Inc. operates in Healthtech, based in DENVER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
In-House Health, Inc. has raised $5.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.4M on 2024-04-05.
Most recent recorded round closed around 2024-04-05.
Valuation (modeled)modeled
Provath models In-House Health, Inc. at approximately $29M (range $6.9M–$67M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.71× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era. Within the normal band (71% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2.2 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 58% of Healthtech peers (2138 compared).
Modeled value ranks above 51% of those peers.
Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.